PMHNP Scope of Practice for Depression

If you’re a psychiatrist or PMHNP treating depression, you’ve probably asked yourself: Can I legally prescribe antidepressants—or controlled substances like benzos and stimulants—via telehealth?

The short answer: Yes, in most cases. But the details matter—especially if you’re managing complex cases involving controlled medications or practicing across state lines.

Let’s cut through the confusion. Federal telehealth flexibilities introduced during COVID remain in effect through December 31, 2026, and most states now embrace telemedicine for mental health care. But there are nuances around controlled substances, scope of practice for NPs, and state-specific prescribing rules that every depression provider needs to understand.

This guide breaks down what’s actually allowed, what’s changing, and what you need to do to stay compliant while growing your practice.

Federal Rules: DEA Telehealth Flexibilities Extended Through 2026

The Current Situation

As of early 2026, you can prescribe controlled substances via telehealth without an initial in-person visit, thanks to temporary DEA extensions. This includes:

• Schedule II medications (Adderall, Ritalin for ADHD comorbid with depression)
• Schedule III-V medications (benzodiazepines for anxiety, esketamine for treatment-resistant depression, sleep aids)
• Non-controlled antidepressants (SSRIs, SNRIs, bupropion—no federal restrictions)

The DEA and HHS announced a fourth extension in January 2026, maintaining COVID-era telemedicine rules through December 31, 2026. This prevents the so-called ‘telemedicine cliff’ that would have forced providers to see patients in person before prescribing any controlled medication.

What this means for depression providers:
You can initiate treatment for a new patient experiencing depression and anxiety via video visit, prescribe an SSRI plus a short-term benzodiazepine if clinically appropriate, and stay fully compliant with federal law. No in-person visit required—for now.

The Ryan Haight Act (And Why It’s Still Suspended)

Normally, the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 requires at least one in-person medical evaluation before prescribing controlled substances via telemedicine. But that requirement has been suspended since March 2020 under public health emergency declarations and subsequent DEA extensions.

The current extension runs through the end of 2026. After that, the DEA is expected to finalize permanent rules that will include:

• A Special Registration for Telemedicine allowing providers to prescribe Schedule III-V controlled substances without in-person exams
• An Advanced Telemedicine Prescribing registration specifically for board-certified psychiatrists to prescribe Schedule II medications (like stimulants) via telehealth without an in-person visit
• Registration requirements for telemedicine platforms themselves (to prevent ‘pill mill’ abuses)

Bottom line: Psychiatrists will likely have clear pathways to continue teleprescribing controlled substances beyond 2026. The DEA’s proposed rules explicitly recognize psychiatry as a specialty where remote prescribing is medically appropriate and necessary for access.

For now, document that you’re operating under the COVID-era telehealth exception when prescribing controlled substances remotely. When the new rules take effect, expect to complete a special registration process—but the core ability to treat depression patients via telemedicine should remain intact.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State Telehealth Prescribing Rules: What’s Different for Depression Care

While federal rules govern controlled substances, state laws determine the baseline for telehealth practice and prescribing. Most states now allow telemedicine evaluations to establish a valid patient relationship for prescribing—but a few impose specific restrictions.

General Standards Across States

Nearly every state requires:

• A valid practitioner-patient relationship established via live audio-visual consultation (not just an online form)
• Standard of care equivalent to in-person treatment
• Electronic prescribing for controlled substances (with limited exceptions)
• PDMP checks before prescribing controlled medications

For routine depression management—prescribing SSRIs, SNRIs, or bupropion after a psychiatric evaluation—telehealth is widely accepted as appropriate standard of care. Most first-line antidepressants are non-controlled, so they face no additional federal telehealth restrictions.

State-Specific Rules That Matter

Texas: Watch Out for Chronic Pain Restrictions

Texas allows teleprescribing for psychiatric conditions but has a specific prohibition on treating chronic pain with controlled substances via telemedicine unless stringent conditions are met (recent in-person or video exam within 90 days, documented medical necessity).

For depression providers: This typically doesn’t affect your practice—treating depression, anxiety, or ADHD isn’t ‘chronic pain management.’ But if you’re managing a patient with both major depression and chronic pain on benzodiazepines or opioids, be aware of this restriction and consider coordinating with a physician who can see the patient in person for pain management.

Texas also requires video for new patient evaluations (phone-only is insufficient to establish a relationship). And PMHNPs in Texas must have a Prescriptive Authority Agreement with a supervising physician—no independent practice yet.

Florida: The Psychiatric Exception for Schedule II Prescribing

Florida law explicitly prohibits teleprescribing Schedule II controlled substances—except for four situations:

1. Treatment of psychiatric disorders
2. Inpatient hospital care
3. Hospice care
4. Nursing home residents

This is good news for psychiatrists treating depression. If you’re prescribing Adderall for a patient with treatment-resistant depression and comorbid ADHD, or using low-dose stimulants for augmentation, you’re covered under the ‘psychiatric disorder’ exception. Just document the psychiatric indication clearly.

Florida also allows out-of-state providers to register for telehealth without obtaining a full Florida license (though you must renew every two years). This makes Florida an attractive market for expanding your telehealth practice—but PMHNPs should note that Florida excludes psychiatric NPs from autonomous practice. You’ll need a supervising psychiatrist even via telehealth.

California, New York, Illinois: NP Independence Unlocks Telehealth Growth

These states have recently expanded full practice authority (FPA) for experienced PMHNPs:

• California (AB 890): Qualified PMHNPs with 3+ years experience can practice independently as of 2024 (‘104 NPs’). No physician oversight required for diagnosing and treating depression, prescribing antidepressants, or managing anxiety with benzodiazepines.

• New York: NPs with over 3,600 hours of practice no longer need a written collaborative agreement with a physician (law made permanent in 2022). You can run a fully independent telepsychiatry practice in New York.

• Illinois: PMHNPs can apply for Full Practice Authority after 4,000 hours of supervised practice plus additional education. Illinois FPA-NPs can prescribe all schedules of controlled substances independently (with a consultation requirement for extended Schedule II opioid prescribing, which rarely applies to psych practice).

What this means: If you’re a PMHNP in one of these states, you can join a telehealth platform like Klarity, see patients independently, and prescribe the full range of depression medications without needing a supervising psychiatrist on paper. This is a huge shift from even five years ago.

Pennsylvania: No Formal Telehealth Law, But Practice is Allowed

Pennsylvania hasn’t passed comprehensive telehealth legislation (bills have stalled over unrelated controversies). But the State Department of Health and professional boards confirm that telehealth is permissible as long as it meets standard of care.

Psychiatrists can prescribe via telehealth after a video evaluation. PMHNPs need a collaborative agreement with a physician—Pennsylvania hasn’t granted NP independence yet. But in practice, many telepsychiatry arrangements work smoothly with remote collaboration.

Pennsylvania is also part of the Interstate Medical Licensure Compact (IMLC), making it easier for out-of-state psychiatrists to obtain licensure and reach underserved rural populations.

Scope of Practice: Psychiatrists vs PMHNPs

Psychiatrists (MD/DO)

As a physician, your scope of practice for treating depression is unrestricted:

• Full diagnostic authority
• Prescribe any medication—non-controlled or controlled, Schedule II through V
• Provide psychotherapy or medication management
• No supervision required in any state

The only regulatory consideration specific to telepsychiatry: you must be licensed in the state where the patient is located at the time of the telehealth visit. No getting around that—even with telehealth flexibilities.

For controlled substances, you need a DEA registration in each state you practice. Most psychiatrists obtain a separate DEA number for each state, though the DEA has discussed streamlining this in the future.

Upcoming advantage: Under the DEA’s proposed Advanced Telemedicine Prescribing registration, board-certified psychiatrists will be explicitly authorized to prescribe Schedule II medications (like stimulants for ADHD comorbid with depression) via telehealth without ever seeing the patient in person. This recognizes psychiatry as a specialty where remote prescribing is clinically appropriate and expands access.

Psychiatric Mental Health Nurse Practitioners (PMHNPs)

PMHNPs are fully trained to diagnose and treat depression, prescribe medications, and manage complex psychiatric conditions. But your scope of practice varies significantly by state:

Full Practice Authority States (California, New York, Illinois, and others):

• After meeting experience requirements (typically 3-4 years), you can practice completely independently
• Diagnose depression, anxiety, ADHD, and other conditions without physician oversight
• Prescribe antidepressants, anxiolytics, stimulants, and other controlled substances
• Open your own practice or join telehealth platforms without needing a collaborating MD

Restricted Practice States (Texas, Florida, Pennsylvania, and others):

• Must have a collaborative agreement or supervisory arrangement with a physician (often a psychiatrist)
• The physician doesn’t need to be present for your telehealth sessions, but they must be available for consultation and involved in your practice protocols
• Prescribing authority may be limited (e.g., Texas restricts NP Schedule II prescribing to certain settings)
• You cannot practice independently or join a telehealth platform without a supervising physician on record

Practical Implications

For Klarity Health and similar platforms, this matters in practice setup:

• A psychiatrist in any state can join and see patients independently (just need the right licenses)
• A PMHNP in California, New York, or Illinois (with FPA) can also join and practice independently
• A PMHNP in Texas, Florida, or Pennsylvania will need the platform to pair them with a collaborating psychiatrist—either through a formal supervisory arrangement or by having a staff psychiatrist who oversees NP prescribing

The good news: states are moving toward NP independence. The trend over the past five years has been expansion of full practice authority, driven by provider shortages and evidence that NPs deliver safe, effective care. More states are likely to follow California, New York, and Illinois in the coming years.

What About Specific Depression Medications?

Let’s break down prescribing rules by drug category:

Non-Controlled Antidepressants (SSRIs, SNRIs, Bupropion, Mirtazapine)

No federal or state telehealth restrictions. You can prescribe these exactly as you would in person, after a proper psychiatric evaluation via video. This is the bread and butter of depression treatment and the easiest category to manage via telehealth.

Benzodiazepines (Schedule IV: Xanax, Ativan, Klonopin)

Allowed under current DEA telehealth flexibilities through 2026. Many depression patients also have anxiety or insomnia requiring short-term benzodiazepine use. You can initiate these via telehealth for new patients right now.

State considerations: No states outright ban teleprescribing benzos (as long as it’s not for chronic pain in Texas). But you must follow standard prescribing practices—check the state PDMP, document medical necessity, have a plan for tapering or discontinuation, and counsel on risks.

Stimulants (Schedule II: Adderall, Ritalin, Vyvanse)

Allowed under DEA telehealth extension through 2026. This is particularly relevant for patients with treatment-resistant depression and comorbid ADHD, or cases where you’re using low-dose stimulants to augment antidepressant response.

State exceptions:

• Florida: Explicitly allowed if prescribing for a ‘psychiatric disorder’
• Texas: No specific prohibition for psychiatric use (the chronic pain ban doesn’t apply here)
• Other states: Follow federal rules—currently permissive

Post-2026: Psychiatrists will likely be able to continue via the proposed DEA special registration. NPs may face additional requirements depending on final rules.

Esketamine (Spravato) for Treatment-Resistant Depression

Schedule III medication with FDA REMS requirements. You can prescribe esketamine via telehealth for the evaluation and management, but the medication itself must be administered in a certified healthcare setting under direct observation (due to dissociative side effects and abuse potential). Patients cannot take it home.

Practically, this means you might do the psychiatric assessment via video, write the prescription, and coordinate with a local REMS-certified clinic where the patient receives supervised administration.

Other Controlled Adjuncts (e.g., Low-Dose Ketamine Infusions, Sleep Aids)

Ambien, Lunesta, trazodone (for insomnia in depression): Currently allowed via telehealth. Follow state prescribing guidelines and PDMP checks.

Off-label treatments like gabapentin or certain mood stabilizers: If they’re non-controlled, no telehealth restrictions. If controlled (e.g., pregabalin in some states), follow controlled substance rules.

The Economics: Why Telehealth Makes Sense for Depression Providers

Let’s talk about the business case—because understanding the regulatory landscape is only useful if you can actually build a sustainable practice around it.

The DIY Marketing Reality

If you’re considering building your own private practice and handling your own patient acquisition, here’s what it actually costs:

SEO (Search Engine Optimization):

• Realistic timeline: 6-12 months before you see meaningful patient flow
• Requires consistent content creation, technical optimization, local listings management
• Most solo providers either lack the expertise or don’t have time to do this while also seeing patients
• Even if you hire an SEO consultant, expect $1,500-3,000/month for several months with no guarantee of results

Google Ads (PPC):

• Mental health keywords are expensive: $15-40+ per click
• Conversion rates from click to booked appointment are typically 2-5%
• Realistic cost per booked patient: $200-400+
• Monthly ad spend to generate consistent patient flow: $2,000-5,000+
• Requires ongoing optimization, A/B testing, landing page development

Psychology Today and Directory Listings:

• Monthly subscription fees: $30-50/month per directory
• But you’re competing with hundreds of other providers on the same search page
• Patients often comparison-shop, leading to low conversion rates
• Zocdoc charges $35-100+ per booking plus monthly subscription fees
• Total monthly cost across multiple directories adds up quickly

Reality check: When you factor in all costs—agency fees, ad spend, platform subscriptions, staff time to handle and qualify leads, no-shows from cold leads, months of investment before results—acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+. And that’s only if you know what you’re doing.

For providers just starting out or trying to scale quickly, this is a significant financial gamble with uncertain ROI.

The Platform Alternative: Guaranteed ROI

This is where a model like Klarity Health’s makes economic sense:

Instead of spending thousands per month on marketing with no guaranteed results, you pay only when a qualified patient books an appointment. Think of it as a standard listing fee per new patient lead—similar to Zocdoc’s model, but with key advantages:

What you get:

• Pre-qualified patients already matched to your specialty (depression/anxiety) and availability
• No upfront marketing spend or monthly subscription fees
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs for video, EHR, e-prescribing)
• Both insurance and cash-pay patient flow (broader patient base)
• You control your schedule—only accept patients when you have capacity

The economic advantage:
Instead of gambling $3,000-5,000/month on marketing channels that might work eventually, you pay a predictable fee only when you actually see a patient. That’s guaranteed ROI vs. speculative investment.

Can DIY marketing eventually be cost-effective? Sure—IF you have:

• The budget to sustain 6-12 months of investment with limited returns
• The expertise (or money to hire experts) in SEO, PPC, and conversion optimization
• The patience to test, fail, and iterate on campaigns
• The staff time to handle lead qualification and intake

For most providers—especially those starting out, transitioning to telehealth, or looking to scale beyond their immediate geographic area—a platform that handles patient acquisition removes the risk entirely.

State-by-State Quick Reference Table

Note: ‘Full prescribing authority’ means ability to prescribe all medications including controlled substances via telehealth, subject to federal DEA rules currently in effect through 2026.

Frequently Asked Questions

Can I prescribe antidepressants to a new patient I’ve only seen via video?

Yes. In all 50 states, a telehealth video visit establishes a valid practitioner-patient relationship for prescribing non-controlled medications like SSRIs, SNRIs, and bupropion. You must conduct an appropriate psychiatric evaluation (history, mental status exam, suicide risk assessment) and document your clinical decision-making, but there’s no requirement for an in-person visit.

Can I prescribe Xanax or Ativan via telehealth for a patient with depression and anxiety?

Yes, through December 31, 2026 under current DEA telehealth flexibilities. You can initiate benzodiazepines for a new patient via video consultation. After 2026, you’ll likely need to complete a DEA telemedicine registration, but the core ability should remain. Always check your state’s PDMP, document medical necessity, and follow appropriate prescribing guidelines.

What happens after the DEA extension expires at the end of 2026?

The DEA is finalizing permanent rules that will include a Special Registration for Telemedicine allowing continued controlled substance prescribing via telehealth. Board-certified psychiatrists will likely qualify for an Advanced Telemedicine Prescribing registration for Schedule II medications. You’ll need to apply for the registration and possibly meet additional training or reporting requirements, but the expectation is that psychiatric telehealth prescribing will continue largely as it does now.

Do I need separate medical licenses in every state where my patients are located?

Yes. Telehealth doesn’t change licensure requirements—you must be licensed (or hold a valid telehealth registration, where available) in the state where the patient is physically located during the telehealth visit.

Some states participate in the Interstate Medical Licensure Compact (IMLC), which streamlines the process for physicians to obtain licenses in multiple states. Florida offers an out-of-state telehealth registration that’s less burdensome than a full license. But in general, plan to obtain full licensure for each state where you’ll see significant patient volume.

As a PMHNP, can I practice independently via telehealth?

It depends on the state. In California (with AB 890 qualification), New York (after 3,600 hours), and Illinois (with FPA), yes—you can practice completely independently via telehealth.

In Texas, Florida, and Pennsylvania, you need a collaborative agreement or supervisory arrangement with a physician. The good news: many telehealth platforms can help facilitate these arrangements, and the supervising physician doesn’t need to be on every call with you.

Can I prescribe Adderall via telehealth for a patient with depression and ADHD?

Yes, under current federal rules through 2026. Adderall is Schedule II, and the DEA telehealth extension allows you to prescribe it via video consultation after an appropriate evaluation.

State note: In Florida, this is explicitly allowed under the ‘psychiatric disorder’ exception. In other states, follow federal guidance. After 2026, psychiatrists will likely continue via a special registration; rules for NPs are still being finalized.

What about patients who live in one state but are temporarily in another?

The patient’s physical location at the time of the telehealth visit determines which state’s laws apply and which state license you need. If your patient usually lives in California but is visiting family in Texas during your appointment, you need a Texas license (or they need to return to California for the visit).

This can get complicated for patients who travel frequently. Some providers ask patients to confirm their location at the start of each visit and maintain documentation.

Do insurance companies cover telehealth for depression treatment?

Yes, in most cases. Federal and state telehealth parity laws require most private insurers and Medicaid programs to cover tele-mental health services equivalent to in-person visits. This was expanded during COVID and has largely been made permanent.

Medicare also covers telehealth for mental health services, with fewer geographic restrictions than other specialties. Cash-pay telehealth is also common in psychiatry, especially for patients who want faster access or more flexible scheduling.

Next Steps: Building Your Telehealth Depression Practice

Understanding the regulations is step one. Step two is building a practice model that actually works economically and clinically.

If You’re Just Starting Out or Expanding to Telehealth

Consider joining an established platform that handles:

• Patient acquisition and marketing (so you’re not gambling thousands on ads)
• Credentialing and contracting with insurance panels
• Telehealth technology (HIPAA-compliant video, integrated EHR, e-prescribing)
• Compliance infrastructure (consent forms, PDMP integrations, state-specific documentation)

This lets you focus on clinical care rather than learning Google Ads or negotiating with Aetna’s credentialing department.

Klarity Health’s model is specifically designed around this: you see patients, we handle everything else. You pay a standard listing fee per new patient lead—no monthly overhead, no marketing risk, no technology headaches. Both insurance and cash-pay patients, matched to your availability and specialty.

If You’re Already Established and Looking to Scale

Even if you have an existing practice, telehealth offers:

• Geographic expansion (see patients in multiple states with the right licenses)
• Evening and weekend flexibility (work from home, pick your own hours)
• Better work-life balance (no commute, schedule around family obligations)
• Higher earning potential (fill gaps in your schedule with telehealth patients between in-person appointments)

The regulatory landscape is as favorable as it’s ever been for psychiatric telehealth. Take advantage of it.

The Bottom Line

Can depression providers prescribe via telehealth in 2025-2026? Absolutely—for both non-controlled antidepressants and controlled medications like benzodiazepines and stimulants, thanks to extended DEA flexibilities.

Will this continue beyond 2026? Almost certainly. The DEA is finalizing permanent rules that explicitly accommodate telepsychiatry, recognizing it as essential for access to mental health care.

What do you need to do?

1. Ensure you’re licensed in the states where your patients are located
2. If you’re a PMHNP, understand your state’s scope of practice and collaboration requirements
3. Follow standard prescribing protocols—PDMP checks, appropriate evaluations, documentation
4. Stay informed about DEA’s final rules expected in late 2026

The opportunity is real. Psychiatric care is moving toward hybrid and telehealth-first models. Provider shortages persist across the country. Patients increasingly expect (and prefer) the convenience of video visits. Reimbursement is stable.

If you’ve been hesitant about telehealth because of regulatory uncertainty, that uncertainty is largely resolved. The path is clear.

Ready to join a telehealth platform that handles patient acquisition, credentialing, and technology—so you can focus on treating patients?

Explore Klarity Health’s provider network. We connect psychiatrists and PMHNPs with patients seeking depression and anxiety treatment via telehealth. You control your schedule, we handle the rest. No upfront costs, no marketing gambles—just a straightforward fee per new patient lead.

See patients. Get paid. Skip the headaches.

Citations and Sources

1. U.S. Department of Health and Human Services. ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026.’ HHS.gov, January 2, 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. U.S. Drug Enforcement Administration. ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Care.’ DEA.gov, January 16, 2025. https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access

3. Florida Legislature. ‘Florida Statutes §456.47 – Use of Telehealth to Provide Services.’ leg.state.fl.us, 2025. https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html

4. Texas Administrative Code, Title 22, Part 9, §174.5. ‘Telemedicine Medical Services, Telemedicine Health Services, and Telehealth Services.’ txrules.elaws.us, updated January 15, 2025. https://txrules.elaws.us/rule/title22chapter174sec.174.5

5. California Board of Registered Nursing. ‘Assembly Bill 890 Implementation – Nurse Practitioner Practice.’ rn.ca.gov, updated January 2023. https://www.rn.ca.gov/practice/ab890.shtml

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,disruptions%20in%20care%20while%20permanent
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=These%20rules%20are%20a%20result,temporary%20rule%20until%20December%202025
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=is%20accessible%20for%20medical%20care,is%20being%20prescribed%20controlled%20medication
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%20law%20previously%20allowed,based%20on%20only
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,person%20setting
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,be
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,through%20a%20telemedicine%20medical%20service